C

Caladrius Biosciences Inc
LSE:0HS8

Watchlist Manager
Caladrius Biosciences Inc
LSE:0HS8
Watchlist
Price: 2.7197 USD -0.56% Market Closed
Market Cap: 52.7m USD
Have any thoughts about
Caladrius Biosciences Inc?
Write Note

Wall Street
Price Targets

0HS8 Price Targets Summary
Caladrius Biosciences Inc

Wall Street analysts forecast 0HS8 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0HS8 is 14.1226 USD with a low forecast of 12.9854 USD and a high forecast of 15.5764 USD.

Lowest
Price Target
12.9854 USD
377% Upside
Average
Price Target
14.1226 USD
419% Upside
Highest
Price Target
15.5764 USD
473% Upside
Caladrius Biosciences Inc Competitors:
Price Targets
000403
Pacific Shuanglin Bio pharmacy Co Ltd
54% Upside
PTGX
Protagonist Therapeutics Inc
23% Upside
NVAX
Novavax Inc
107% Upside
006280
Green Cross Corp
43% Upside
ADAG
Adagene Inc
308% Upside
XNCR
Xencor Inc
44% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
27% Upside
SANA
Sana Biotechnology Inc
313% Upside

Revenue
Forecast

Revenue Estimate
Caladrius Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Caladrius Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Net Income
Forecast

Net Income Estimate
Caladrius Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0HS8's stock price target?
Price Target
14.1226 USD

According to Wall Street analysts, the average 1-year price target for 0HS8 is 14.1226 USD with a low forecast of 12.9854 USD and a high forecast of 15.5764 USD.

Back to Top